Stem cell therapy has shown to improve left ventricular function in patients with
ischemic cardiomyopathy. Serum B type natriuretic peptide (BNP) has been to used to
evaluate the neurohormonal status of congestive heart failure symptoms. The goal of
this study was to determine if serum BNP levels improved in ischemic cardiomyopathy
patients under going stem cell therapy.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to The Journal of Heart and Lung TransplantationAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Identification
Copyright
© 2005 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.
